Neurogene INC S-1 registration statements

Registration statements, filed ahead of a public offering, with the business description and financials a first-time investor sees.

NASDAQ
Neurogene Inc. has filed a registration statement for the resale of 4,000,042 shares of its common stock, including shares issuable upon exercise of pre-funded warrants, by selling stockholders after a recent private placement.